These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37078126)

  • 41. Laboratory approach for diagnosis of toluene-based inhalant abuse in a clinical setting.
    Jain R; Verma A
    J Pharm Bioallied Sci; 2016; 8(1):18-22. PubMed ID: 26957863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neural basis of inhalant abuse.
    Balster RL
    Drug Alcohol Depend; 1998; 51(1-2):207-14. PubMed ID: 9716942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anxiety symptoms in crack cocaine and inhalant users admitted to a psychiatric hospital in southern Brazil.
    Zubaran C; Foresti K; Thorell MR; Franceschini PR
    Rev Assoc Med Bras (1992); 2013; 59(4):360-7. PubMed ID: 23850024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adolescent inhalant abuse: environments of use.
    McGarvey EL; Clavet GJ; Mason W; Waite D
    Am J Drug Alcohol Abuse; 1999 Nov; 25(4):731-41. PubMed ID: 10548445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Volatile substance misuse : clinical considerations, neuropsychopharmacology and potential role of pharmacotherapy in management.
    Garland EL; Howard MO
    CNS Drugs; 2012 Nov; 26(11):927-35. PubMed ID: 23018545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic concordance of DSM-III-R, DSM-IV, and ICD-10 inhalant use disorders.
    Howard MO; Cottler LB; Compton WM; Ben-Abdallah A
    Drug Alcohol Depend; 2001 Feb; 61(3):223-8. PubMed ID: 11164686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medico legal investigations into sudden sniffing deaths linked with trichloroethylene.
    Da Broi U; Colatutto A; Sala P; Desinan L
    J Forensic Leg Med; 2015 Aug; 34():81-7. PubMed ID: 26165664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Item response theory analysis of DSM-IV criteria for inhalant-use disorders in adolescents.
    Perron BE; Vaughn MG; Howard MO; Bohnert A; Guerrero E
    J Stud Alcohol Drugs; 2010 Jul; 71(4):607-14. PubMed ID: 20553671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical complications of glue sniffing.
    Meadows R; Verghese A
    South Med J; 1996 May; 89(5):455-62. PubMed ID: 8638168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome.
    Bowen SE
    Subst Use Misuse; 2011; 46 Suppl 1():68-72. PubMed ID: 21609149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation Z: Adolescent Xenobiotic Abuse in the 21st Century.
    Eggleston W; Stork C
    Adolesc Med State Art Rev; 2015 Dec; 26(3):570-88. PubMed ID: 27282013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Follow-up the outcome of treatment of inhalant users in Northeastern Thailand.
    Watanaphithuk W; Ratanasiri A; Kanato M
    J Med Assoc Thai; 2013 Jul; 96(7):854-9. PubMed ID: 24319858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19.
    Molina MF; Al Saud AA; Al Mulhim AA; Liteplo AS; Shokoohi H
    Am J Emerg Med; 2020 Jul; 38(7):1549.e1-1549.e2. PubMed ID: 32425320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of Inhalant Abuse Legislation.
    Batis JC
    Subst Use Misuse; 2017 Jan; 52(2):175-181. PubMed ID: 27754720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhalant abuse of computer cleaner manifested as angioedema.
    Kurniali PC; Henry L; Kurl R; Meharg JV
    Am J Emerg Med; 2012 Jan; 30(1):265.e3-5. PubMed ID: 21295430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhalant induced mania: An unexplored entity.
    Joshi S; Sapkota N; Sharma P
    Asian J Psychiatr; 2017 Aug; 28():32-33. PubMed ID: 28784391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Five challenges for volatile substance misuse policy and intervention in Australia.
    MacLean SJ; d'Abbs PH
    Drug Alcohol Rev; 2011 Mar; 30(2):223-7. PubMed ID: 21355912
    [No Abstract]   [Full Text] [Related]  

  • 58. Adolescent Inhalant Abuse Results in Adrenal Dysfunction and a Hypermetabolic Phenotype with Persistent Growth Impairments.
    Crossin R; Andrews ZB; Sims NA; Pang T; Mathai M; Gooi JH; Stefanidis A; Oldfield BJ; Lawrence AJ; Duncan JR
    Neuroendocrinology; 2018; 107(4):340-354. PubMed ID: 30208370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Volatile substance abuse.
    Flanagan RJ; Ives RJ
    Bull Narc; 1994; 46(2):49-78. PubMed ID: 7866398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence and clinical significance of inhalant withdrawal symptoms among a national sample.
    Perron BE; Glass JE; Ahmedani BK; Vaughn MG; Roberts DE; Wu LT
    Subst Abuse Rehabil; 2011 Apr; 2011(2):69-76. PubMed ID: 21709745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.